Skip to main content
Signal8

Lunai Bioworks Inc. (LNAI)

Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Lunai Bioworks Inc. logo

Lunai Bioworks Inc.

OTC:LNAIOTC (delisted from Nasdaq, Form 25 effective Nov 12, 2026)Healthcare
Mkt Cap$830K
EV-
Float4.88M
O/S5.03M
VOL1.27M sh
$ Vol$195K
RVOL0.86×
Inst Own3.8%
SI0.4%
Net Cash/Sh-
Dilution
FormDescription
15-12G
SEC Filing
8-K
25
SEC Filing
EFFECT
Notice of Effectiveness
S-8 POS
SEC Filing
POS AM
Post-Effective Amendment
S-8 POS
SEC Filing
8-K
13D/A
10-K
8-K
8.01,9.01
NT 10-K
SEC Filing
13G
Beneficial Ownership Report
8-K
8.01,9.01
8-K
8.01
8-K
8.01,9.01
10-Q
8-K
5.07
8-K/A
3.01
DEFR14A
SEC Filing
8-K
1.01,2.01,3.01,3.02,3.03,5.03,9.01
8-K
8.01,9.01
DEFA14A
Additional Proxy Materials
DEFR14A
SEC Filing
DEF 14A
Definitive Proxy Statement

1-25 of 601

…

Recent SEC filings with analysis

    Lunai Bioworks Inc. (LNAI) SEC Filings: 10-K, 10-Q, 8-K | Signal8